Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference16 articles.
1. Drug repurposing programmes get lift off;Mullard;Nat Rev Drug Discov,2012
2. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020
3. New insights into the antiviral effects of chloroquine;Savarino;Lancet Infect Dis,2006
4. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century;Rolain;Int J Antimicrob Agents,2007
5. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread;Vincent;Virol J,2005
Cited by 335 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the Therapeutic Potential of Defective Interfering Particles in Reducing the Replication of SARS-CoV-2;Mathematics;2024-06-19
2. Syringa reticulata potently inhibits the activity of SARS-CoV-2 3CL protease;Biochemistry and Biophysics Reports;2024-03
3. Premature Closure of Scientific Thinking: Deaths Due to Chloroquine and Hydroxychloroquine Used for COVID-19 Infection;American Journal of Therapeutics;2024-03
4. Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update;Clinical Pathology;2024-01
5. A narrative review on adverse drug reactions of COVID-19 treatments on the kidney;Open Medicine;2024-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3